Alkemy Capital Investments PLC Admission to trading on the Main Market (2905D)

TIDMALK

RNS Number : 2905D

Alkemy Capital Investments PLC

02 March 2022

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT IS AN ADVERTISEMENT AND IS NOT A PROSPECTUS AND NOT AN OFFER FOR SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR INTO ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW. INVESTORS SHOULD NOT PURCHASE OR SUBSCRIBE FOR ANY SHARES REFERRED TO IN THIS ANNOUNCEMENT EXCEPT ON THE BASIS OF INFORMATION IN THE PROSPECTUS (THE "PROSPECTUS") PUBLISHED BY ALKEMY CAPITAL INVESTMENT PLC, IN CONNECTION WITH THE PROPOSED ADMISSION OF ITS ORDINARY SHARES TO THE STANDARD LISTING SEGMENT OF THE OFFICIAL LIST OF THE FINANCIAL CONDUCT AUTHORITY AND TO TRADING ON THE MAIN MARKET FOR LISTED SECURITIES OF LONDON STOCK EXCHANGE PLC (THE "LONDON STOCK EXCHANGE" OR "LSE") (TOGETHER, "ADMISSION"). THE PROSPECTUS IS AVAILABLE ON THE COMPANY'S WEBSITE AT WWW.ALKEMY CAPITAL.CO.UK .

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT IS NOT FOR RELEASE,

PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR INTO ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW.

2 March 2022

Alkemy Capital Investments Plc

("Alkemy" or the "Company)

Admission to trading on the Main Market of the London Stock Exchange

Further to the Company's press release of 25 February 2022 setting out details of its reverse takeover transaction and change of strategy and following the publication of its Prospectus on 25 February 2022, the Company is now pleased to confirm that its entire issued ordinary share capital, consisting of 5,999,999 Ordinary Shares of GBP0.02 each, will be admitted to the Standard Listing segment of the Official List of the FCA and to trading on the London Stock Exchange's Main Market for listed securities. Trading in the Company's shares will commence on the London Stock Exchange at 8.00am today under the ticker symbol: ALK and ISIN: GB00BMD6C023.

The Company is not raising any funds in connection with the admission and will have 5,999,999 ordinary shares of GBP0.02 each in issue. A copy of the Prospectus is available on the Company's website www.alkemycapital.co.uk and the National Storage Mechanism

https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

** Ends **

For further information, please contact:

Sam Quinn

Director, Alkemy Capital Investments Plc

Telephone: [phone]

Email: [e-mail]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ALSUAURRUKUORUR

(END) Dow Jones Newswires

March 02, 2022 02:30 ET (07:30 GMT)